Underlying disease was documented for 19 (42%) patients, including 16 with immunodeficiency acquired by treatment or disease (Figure 2), 1 with inborn error of immunity (NEMO [nuclear factor κB essential modulator] mutation), and 2 with prior chronic pulmonary diseases. Here, IKBKG is linked to immune system disorder.